These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24972668)

  • 1. The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders.
    Savarino E; De Cassan C; Bodini G; Furnari M; de Bortoli N; Savarino V
    J Gastroenterol; 2014 Sep; 49(9):1362-3. PubMed ID: 24972668
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter by E. Savarino et al. regarding "The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders".
    Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
    J Gastroenterol; 2014 Sep; 49(9):1364-5. PubMed ID: 24974095
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
    Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
    J Gastroenterol; 2014 Apr; 49(4):628-37. PubMed ID: 23653056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia.
    Miwa H; Haruma K; Sakamoto S; Sanada K; Hiroi S; Kinoshita Y
    J Gastroenterol Hepatol; 2015 May; 30(5):834-41. PubMed ID: 25559435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high chromogranin A: Is it always a tumor?
    Turhan Iyidir O; Cimen AR; Değertekin CK; Baloş Törüner F; Cakır N; Arslan M
    Turk J Gastroenterol; 2013; 24(2):186-7. PubMed ID: 23934470
    [No Abstract]   [Full Text] [Related]  

  • 6. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
    Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
    Trials; 2016 Apr; 17():175. PubMed ID: 27036555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study.
    Haruma K; Kinoshita Y; Sakamoto S; Sanada K; Hiroi S; Miwa H
    Intern Med; 2015; 54(7):695-701. PubMed ID: 25832928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sticky Palms Following Use of Proton-Pump Inhibitors.
    Alkeraye S; Baclet Y; Delaporte E
    JAMA Dermatol; 2016 Jun; 152(6):722-3. PubMed ID: 26962767
    [No Abstract]   [Full Text] [Related]  

  • 9. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tapering off is the most effective measure for protein pump inhibitor discontinuation].
    Steurer J
    Praxis (Bern 1994); 2015 Jan; 104(2):105. PubMed ID: 25586436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
    Paikka N
    Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD.
    Kennedy M; Ford AC
    Aliment Pharmacol Ther; 2012 Jul; 36(2):207; author 207-8. PubMed ID: 22703466
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
    J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is acid relevant in the genesis of dyspeptic symptoms associated with nonerosive reflux disease?
    Savarino V; Savarino E
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):252-4. PubMed ID: 18334866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate use of proton pump inhibitors.
    Molloy D; Molloy A; O'Loughlin C; Falconer M; Hennessy M
    Ir J Med Sci; 2010 Mar; 179(1):73-5. PubMed ID: 19763673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
    Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
    World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?).
    Stanghellini V; Frisoni C
    Am J Gastroenterol; 2010 Dec; 105(12):2632-4. PubMed ID: 21131930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.
    Fitzpatrick AM; Holbrook JT; Wei CY; Brown MS; Wise RA; Teague WG;
    J Allergy Clin Immunol Pract; 2014; 2(5):579-86.e7. PubMed ID: 25213052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methods.
    Tang M; Blake KV; Lima JJ; Mougey EB; Franciosi J; Schmidt S; Hossain MJ; Cobbaert M; Fischer BM; Lang JE
    Contemp Clin Trials; 2019 Mar; 78():27-33. PubMed ID: 30659924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.
    Laine L; Nagar A
    Am J Gastroenterol; 2016 Jul; 111(7):913-5. PubMed ID: 27113114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.